Seaport Therapeutics Closes $225 Million Financing Round

Posted by ISPE Boston
On October 24, 2024

Neuropsychiatric medicines company Seaport Therapeutics has closed an oversubscribed $225 million Series B financing round. The financing brings the total capital raised by Seaport to $325 million since the company’s launch in April 2024. Seaport will use the proceeds to advance its clinical-stage pipeline of first and best-in-class medicines through important clinical milestones as well […]

Biotech Veteran Launches RNAi Startup

Posted by ISPE Boston
On October 24, 2024

City Therapeutics has launched with $135 million in financing and a vision to lead the future of RNA interference (RNAi)-based medicine. Led by executive chair John Maraganore, founding CEO of Alnylam Pharmaceuticals, the startup aims to harness next-generation engineering of small interfering RNAs (siRNAs) – the “trigger” molecules that mediate RNAi – to build a […]

Upcoming Educational Program on Cell & Gene Therapy

Posted by Jack Campion
On October 23, 2024

Join us on Thursday, November 14th, 2024, for an exciting opportunity to dive into the world of Cell & Gene Therapy at Northeastern University’s Innovation Campus in Burlington, MA. This educational event will highlight the distinct challenges in commercializing autologous therapies and provide a unique learning experience for both newcomers and seasoned professionals. Program Highlights: […]

$21.4M in State Tax Breaks for 19 Biotechs

Posted by ISPE Boston
On October 18, 2024

The Healey-Driscoll administration and the Massachusetts Life Sciences Center (MLSC) have announced $21.4 million in tax incentive awards to 19 life sciences companies. The awards, provided through the MLSC’s Tax Incentive Program, are expected to create 1,155 new life sciences industry jobs in Massachusetts. The MLSC Tax Incentive program is offered to companies engaged in life […]

FDA Approves First-in-Class Schizophrenia Drug from BMS

Posted by ISPE Boston
On October 18, 2024

The FDA has approved Cobenify, an oral medication for the treatment of schizophrenia in adults. Cobenify represents the first new class of schizophrenia medicine in several decades and introduces a fundamentally new approach to treating the illness. “Today’s landmark approval of our first-in-class treatment for schizophrenia marks an important milestone for the community, where after more […]

Introducing New Board Member Sean Keenan

Posted by ISPE Boston
On October 14, 2024

A big welcome to Sean Keenan, the newest member of the Chapter’s Board of Directors! Although new to the Board, Sean has long been an active Chapter volunteer, including Chair of the Emerging Leaders Committee (ELC). In order to get to know him better, we asked Sean a few questions about his background as a […]

Webinar Invitation – Recent Advances in Cell and Gene Therapy

Posted by Sunny Tam
On October 10, 2024

You’re invited! Longtime ISPE Boston Area Chapter board member, Professor Sunny Tam, is organizing an international online panel on Recent Advances in Cell & Gene Therapy as a collaboration between Northeastern University and The Hong Kong University of Science and Technology. Panelists include: Professor Lo Yuk Lam, President, Hong Kong Bio-Med Innotech Association Dr. Simon […]

A Rainy but Fun Fall Golf Tournament

Posted by Dan Kenny
On October 9, 2024

On a rainy Monday, ISPE members and non-members gathered at Indian Pond Golf Club for the annual Fall Golf Tournament to benefit the ISPE Boston Scholarship Foundation. Despite a brief rain delay, foursomes set out in good spirits for a day out on the golf course. As the day wore on, and the rain continued, […]

Chapter Member Anniversaries: October 2024

Posted by ISPE Boston
On October 9, 2024

Please congratulate the following members celebrating milestone anniversaries in October 2024. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Louis R. Cicchese, MBA, BSChem, Moderna Therapeutics Aaron Conant, Alnylam Pharmaceuticals Patrick J. Cunneen, Allegheny Bradford Corp. William G. Devine, Pharma-Tech Services Ric Feldt, Jeff Smith & Associates […]

Welcome New Members September 2024

Posted by ISPE Boston
On October 9, 2024

We would like to introduce the Members who joined ISPE in September 2024, welcome them to the Chapter, and encourage them (and all our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And the […]

Page 7 of 118«‹5 678 9 ›»